Cargando…
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
The human gut microbiome is a complex ecosystem of fundamental importance to human health. Our increased understanding of gut microbial composition and functional interactions in health and disease states has spurred research efforts examining the gut microbiome as a valuable target for therapeutic...
Autores principales: | Carlucci, Christian, Petrof, Elaine O., Allen-Vercoe, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264253/ https://www.ncbi.nlm.nih.gov/pubmed/27720396 http://dx.doi.org/10.1016/j.ebiom.2016.09.029 |
Ejemplares similares
-
Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018) -
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis
por: Mintz, Michael, et al.
Publicado: (2018) -
Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficile Infection
por: Zainah, Hadeel, et al.
Publicado: (2012) -
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
por: Jaramillo, Arturo P, et al.
Publicado: (2023) -
Bezlotoxumab Therapy for Recurrent Clostridium difficile Infection in an Ulcerative Colitis Patient
por: Fein, Aaron, et al.
Publicado: (2022)